4//SEC Filing
O'Day Daniel Patrick 4
Accession 0001127602-25-017333
CIK 0000882095other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 6:55 PM ET
Size
8.3 KB
Accession
0001127602-25-017333
Insider Transaction Report
Form 4
O'Day Daniel Patrick
DirectorChairman & CEO
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-06-10−10,425→ 108,923 total→ Common Stock (10,425 underlying) - Exercise/Conversion
Common Stock
2025-06-10+10,425→ 630,693 total - Tax Payment
Common Stock
2025-06-10$110.09/sh−4,968$546,927→ 625,725 total
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001638643
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 6:55 PM ET
- Size
- 8.3 KB